Three Risks Sponsors Must Solve Before Adopting Digital Health Tools

The Three Risks Sponsors Must Solve Before Adopting Digital Health Tools As the cost of pharmaceutical research approaches $900 million per new drug , sponsors are looking for ways to make decentralized clinical trials more streamlined and cost-effective . Digital health technologies (DHTs) are proving to be one of the best ways that sponsors can do just that. For example, wearables and sensors provide continuous, high-quality data that can merge with postmarket analysis and reduce reliance on physical testing sites, while electronic forms, smart devices, and telemedicine platforms lower the p